摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-N-(4-(4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide | 937263-57-5

中文名称
——
中文别名
——
英文名称
(E)-N-(4-(4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide
英文别名
(E)-4-(dimethylamino)-N-[4-(4-imidazo[1,2-a]pyridin-7-yloxy-3-methylanilino)quinazolin-6-yl]but-2-enamide
(E)-N-(4-(4-(imidazo[1,2-a]pyridin-7-yloxy)-3-methylphenylamino)quinazolin-6-yl)-4-(dimethylamino)but-2-enamide化学式
CAS
937263-57-5
化学式
C28H27N7O2
mdl
——
分子量
493.568
InChiKey
CMFXELZYGBQTMG-SNAWJCMRSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.6
  • 重原子数:
    37
  • 可旋转键数:
    8
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    96.7
  • 氢给体数:
    2
  • 氢受体数:
    7

反应信息

点击查看最新优质反应信息

文献信息

  • N4-PHENYL-QUINAZOLINE-4-AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
    申请人:ARRAY BIOPHARMA, INC.
    公开号:US20140023643A1
    公开(公告)日:2014-01-23
    This invention provides compounds of Formula I wherein B, G, A, E, R 1 , R 2 , R 3 , m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
    本发明提供了I式化合物,其中B、G、A、E、R1、R2、R3、m和n如本文所定义,它们可用作I型受体酪氨酸激酶抑制剂,并且在哺乳动物的增殖过度疾病治疗中使用的方法。
  • N4-Phenyl-Quinazoline-4-Amine Derivatives and Related Compounds as ErbB Type I Receptor Tyrosine Kinase Inhibitors for the Treatment of Hyperproliferative Diseases
    申请人:Lyssikatos Joseph P.
    公开号:US20110034689A1
    公开(公告)日:2011-02-10
    This invention provides compounds of Formula I wherein B, G, A, E, R 1 , R 2 , R 3 , m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
    本发明提供了式I中的化合物,其中B、G、A、E、R1、R2、R3、m和n的定义如本文所述,这些化合物可用作I型受体酪氨酸激酶抑制剂,并且可以用于哺乳动物的增殖过度性疾病的治疗方法。
  • N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
    申请人:ARRAY BIOPHARMA, INC.
    公开号:US10780073B2
    公开(公告)日:2020-09-22
    This invention provides compounds of Formula I wherein B, G, A, E, R1, R2, R3, m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
    本发明提供了式 I 的化合物 其中 B、G、A、E、R1、R2、R3、m 和 n 如本文所定义,可用作 I 型受体酪氨酸激酶抑制剂,并可用于治疗哺乳动物的过度增殖性疾病。
  • N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
    申请人:Array Biopharma Inc.
    公开号:EP1971601B1
    公开(公告)日:2009-10-21
  • N4-phenyl-quinazoline-4 -amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases
    申请人:Array BioPharma Inc.
    公开号:US20210008023A1
    公开(公告)日:2021-01-14
    This invention provides compounds of Formula I wherein B, G, A, E, R 1 , R 3 , R 4 , m and n are as defined herein, which are useful as type I receptor tyrosine kinase inhibitors, and methods of use thereof in the treatment of hyperproliferative disorders in mammals.
查看更多